We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Drug Free Solutions Inc (CE) | USOTC:DSOL | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 15, 2013
LIVING BREATH PROJECT,
INC.
(Exact name of registrant as specified in its
charter)
Nevada | 333-175525 | 99-0365611 |
(State or Other Jurisdiction | (Commission File | (I.R.S. Employer |
of Incorporation) | Number) | Identification Number) |
P.O. Box 4250, East Hampton, New York
11937
(Address of principal executive offices, including zip
code)
800-422-0691
(Registrants telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On October 15, 2013, upon authority of the majority shareholder of the Registrants common stock, par value $0.001 per share, and the sole member of the Board of Directors, the Registrant filed an amendment to the Registrants Articles of Incorporation to change the name of the Registrant to Drug Free Solution Inc.
Item 9.01 | Financial Statements and Exhibits |
Exhibit No. | Description of Exhibit |
3.1 | Certificate of Amendment |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LIVING BREATH PROJECT, INC. | ||
Date: October 16, 2013 | By: | /s/ Genie, OMalley |
Name: Genie OMalley | ||
Title: Chief Executive Officer |
EXHIBIT INDEX
Exhibit No. | Description of Exhibit |
3.1 | Certificate of Amendment |
1 Year Drug Free Solutions (CE) Chart |
1 Month Drug Free Solutions (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions